KUALA LUMPUR, June 16 (Bernama) — Duopharma Biotech Berhad (“Duopharma Biotech” or “the Company“) hosted the Third (3rd) Halal Pharmaceuticals Symposium 2022 on 15th June 2022, as part of The Company’s continuing quest to spearhead efforts to capture the global halal pharmaceuticals market by facilitating the sharing of best practices, achievements and international collaborations to resolve challenges, advance global standards and jointly shape the industry.
Themed The Emergence of Global Best Practices for Halal Pharmaceuticals this year, the international symposium that has been organised by Duopharma Biotech since 2016 aims to reinforce the true meaning of halal pharmaceuticals as the Company works to ensure that the industry supply chains follow rigorous international halal standards to produce high-quality products at every stage of the value chain. In addition, the symposium gathers international experts, industry leaders and standards and regulatory agencies, including the Organization of Islamic Cooperation (“OIC“)’s Standards and Metrology Institute for Islamic Countries (“SMIIC“) to advance halal pharma’s integration into the global healthcare system.
http://mrem.bernama.com/viewsm.php?idm=43440
